Topical "Non-Aromatic Very Rich in Steranes" (NAVS) Naphthalan for the Treatment of Oral Mucosal Diseases
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effectiveness of topical NAVS naphthalan in the treatment of oral
lichen planus (OLP) and recurrent aphthous stomatitis (RAS). Half of participants with OLP
and RAS will receive topical NAVS naphthalan in adhesive paste, while the other half will
receive 0.05%-betamethasone dipropionate in adhesive paste. Our hypothesis is that NAVS could
be efficient in the treatment of OLP and RAS, with effects comparable to that of topical
steroids.
Phase:
Phase 2
Details
Lead Sponsor:
Ivan Alajbeg
Collaborator:
Ministry of Science, Education and Sport, Republic of Croatia